Latest filing published 12 Feb 2026 for HCA Healthcare, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael S. Cuffe is a declared insider of HCA Healthcare, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 28 January 2016 and 10 February 2026, the trades on record add up to 22 filings.
On the market, this insider has only sold: 6 sales, €6.7M in total. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 7 share grants and 7 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 12 February 2026: a share grant, in HCA Healthcare, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations